Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00DIM
|
|||
| Former ID |
DIB001049
|
|||
| Drug Name |
Monohydroxyethylrutoside
|
|||
| Synonyms |
Frederine; MonoHER; VUF-5434; Mono-7-hydroxyethylrutoside
Click to Show/Hide
|
|||
| Indication | Cardiovascular disease [ICD-11: BA00-BE2Z; ICD-10: I00-I99] | Phase 1 | [1] | |
| Company |
Universiteit Maastricht
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Iron (Fe) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A phase I study of monohydroxyethylrutoside in healthy volunteers. Cancer Chemother Pharmacol. 2006 May;57(5):678-84. | |||
| REF 2 | Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin. Clin Cancer Res. 1997 Oct;3(10):1747-54. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.